NO20051947L - Regulering av aggrecan genekspresjonen ved bruk av spesifikk og selektiv elektriske og elektromagnetiske signaler - Google Patents

Regulering av aggrecan genekspresjonen ved bruk av spesifikk og selektiv elektriske og elektromagnetiske signaler

Info

Publication number
NO20051947L
NO20051947L NO20051947A NO20051947A NO20051947L NO 20051947 L NO20051947 L NO 20051947L NO 20051947 A NO20051947 A NO 20051947A NO 20051947 A NO20051947 A NO 20051947A NO 20051947 L NO20051947 L NO 20051947L
Authority
NO
Norway
Prior art keywords
gene expression
specific
regulation
cartilage
electromagnetic signals
Prior art date
Application number
NO20051947A
Other languages
English (en)
Inventor
Carl T Brighton
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of NO20051947L publication Critical patent/NO20051947L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Det beskrives fremgangsmåter og innretninger for regulering av aggrecan genekspresjonen i bruskceller via pålegging av felt som genereres av spesifikke og selektive, elektriske og elektiomagnetiske signaler, ved behandling av sykt eller skadet bruskvev. Med genekspresjon menes oppregulering eller nedregulering av prosessen hvorved spesifikke deler (gener) av det humane genom (DNA) tianskriberes til mRNA og deretter tianslateres til protein. Det tilveiebringes metoder og irmretninger for måkettet behandling av skadet eller sykt bruskvev som inkluderer generering av spesifikke og selektive, elektriske og elektiomagnetiske signaler som genererer felt som er optimalisert for aggrecan genekspresjon og eksponering av bruskvevet til felt generert av spesifikke og selektive signaler for å regulere aggrecan genekspresjonen i slikt bruskvev. De resulterende metoder og umretninger er nyttige for målrettet behandling av osteoartritt, reumatoid artritt, bruskskade og bruskdefekter.
NO20051947A 2002-09-26 2005-04-21 Regulering av aggrecan genekspresjonen ved bruk av spesifikk og selektiv elektriske og elektromagnetiske signaler NO20051947L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/255,241 US7374916B2 (en) 2000-02-23 2002-09-26 Regulation of aggrecan gene expression using specific and selective electrical and electromagnetic signals
PCT/US2003/030333 WO2004029210A2 (en) 2002-09-26 2003-09-24 Resolution of aggrecan gene expression using specific and selective electrical and electromagnetic signals

Publications (1)

Publication Number Publication Date
NO20051947L true NO20051947L (no) 2005-04-21

Family

ID=32041741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051947A NO20051947L (no) 2002-09-26 2005-04-21 Regulering av aggrecan genekspresjonen ved bruk av spesifikk og selektiv elektriske og elektromagnetiske signaler

Country Status (14)

Country Link
US (1) US7374916B2 (no)
EP (1) EP1560553B1 (no)
JP (1) JP4344321B2 (no)
KR (1) KR20050059198A (no)
CN (1) CN100446743C (no)
AU (1) AU2003276961A1 (no)
BR (1) BR0314807A (no)
CA (1) CA2500212A1 (no)
ES (1) ES2622076T3 (no)
MX (1) MXPA05003259A (no)
NO (1) NO20051947L (no)
NZ (1) NZ539310A (no)
WO (1) WO2004029210A2 (no)
ZA (1) ZA200503041B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465566B2 (en) 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of genes via application of specific and selective electrical and electromagnetic signals
US7981611B2 (en) * 2000-02-23 2011-07-19 The Trustees Of The University Of Pennsylvania Regulation of fibroblastic growth factor-2 (FGF-2) gene expression in living cells with the application of specific and selective electric and electromagnetic fields
US8313908B2 (en) 2000-02-23 2012-11-20 The Trustees Of The University Of Pennsylvania Regulation of stem cell gene production with specific and selective electric and electromagnetic fields
US7465546B2 (en) * 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of transforming growth factor-beta (TGF-β) gene expression in living cells via the application of specific and selective electric and electromagnetic fields
MXPA06005358A (es) * 2003-11-14 2006-07-10 Univ Pennsylvania Metodo y aparato para el tratamiento de la osteoartritis, enfermedades de los cartilagos, defectos y lesiones en la cadena humana.
US9433797B2 (en) 2003-12-05 2016-09-06 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurodegenerative conditions
US20070026514A1 (en) * 2005-03-07 2007-02-01 Pilla Arthur A Electromagnetic treatment apparatus for enhancing pharmacological, chemical, and topical agent effectiveness and method for using same
US9656096B2 (en) 2003-12-05 2017-05-23 Rio Grande Neurosciences, Inc. Method and apparatus for electromagnetic enhancement of biochemical signaling pathways for therapeutics and prophylaxis in plants, animals and humans
US10350428B2 (en) 2014-11-04 2019-07-16 Endonovo Therapetics, Inc. Method and apparatus for electromagnetic treatment of living systems
US7744524B2 (en) * 2003-12-05 2010-06-29 Ivivi Health Sciences, Llc Apparatus and method for electromagnetic treatment of plant, animal, and human tissue, organs, cells, and molecules
US9427598B2 (en) 2010-10-01 2016-08-30 Rio Grande Neurosciences, Inc. Method and apparatus for electromagnetic treatment of head, cerebral and neural injury in animals and humans
US8961385B2 (en) 2003-12-05 2015-02-24 Ivivi Health Sciences, Llc Devices and method for treatment of degenerative joint diseases with electromagnetic fields
US9415233B2 (en) 2003-12-05 2016-08-16 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological pain
US9440089B2 (en) 2003-12-05 2016-09-13 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological injury or condition caused by a stroke
US20110112352A1 (en) * 2003-12-05 2011-05-12 Pilla Arthur A Apparatus and method for electromagnetic treatment
US20130218235A9 (en) * 2005-03-07 2013-08-22 Arthur A. Pilla Excessive fibrous capsule formation and capsular contracture apparatus and method for using same
AU2005206794B2 (en) * 2004-01-12 2010-09-16 The Trustees Of The University Of Pennsylvania Up-regulation of bone morphogenetic protein (BMP) gene expression in bone cells by electromagnetic signals
NZ551316A (en) 2004-04-19 2008-03-28 Ivivi Technologies Inc Electromagnetic treatment apparatus and method
US20090018613A1 (en) * 2006-08-02 2009-01-15 Genestim, Llc Regulation of vascular endothelial growth factor (vegf) gene expression in tissue via the application of electric and/or electromagnetic fields
US8343027B1 (en) 2012-01-30 2013-01-01 Ivivi Health Sciences, Llc Methods and devices for providing electromagnetic treatment in the presence of a metal-containing implant
EP3131628A4 (en) 2014-04-16 2017-11-22 Ivivi Health Sciences, LLC A two-part pulsed electromagnetic field applicator for application of therapeutic energy
KR101675414B1 (ko) 2014-11-17 2016-11-11 경상대학교산학협력단 뼈 재생장치
WO2018089795A1 (en) 2016-11-10 2018-05-17 Qoravita LLC System and method for applying a low frequency magnetic field to biological tissues

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4506674A (en) 1981-11-10 1985-03-26 Trustees Of The University Of Pennsylvania Method of stimulating osteogenesis with distributed port cathode
US4430999A (en) 1981-11-10 1984-02-14 Trustees Of The University Of Pennsylvania Osteogenesis stimulating cathode assembly for use with an internal fixation device
US4442846A (en) 1981-11-10 1984-04-17 University Of Pennsylvania Distributed port bone-piercing cathode for electrically stimulated osteogenesis
US4509520A (en) 1982-02-22 1985-04-09 Biolectron, Inc. Electrical stimulating apparatus
US4549547A (en) 1982-07-27 1985-10-29 Trustees Of The University Of Pennsylvania Implantable bone growth stimulator
US4487834A (en) 1982-09-17 1984-12-11 Biolectron, Inc. Electrical stimulation of articular chondrocytes
US4467808A (en) * 1982-09-17 1984-08-28 Biolectron, Inc. Method for preventing and treating osteoporosis in a living body by using electrical stimulation non-invasively
US4467809A (en) * 1982-09-17 1984-08-28 Biolectron, Inc. Method for non-invasive electrical stimulation of epiphyseal plate growth
US5269746A (en) 1982-12-20 1993-12-14 Jacobson Jerry I Therapeutic treatment of mammals for epilepsy and Parkinson's disease
US4535775A (en) 1983-02-10 1985-08-20 Biolectron, Inc. Method for treatment of non-union bone fractures by non-invasive electrical stimulation
IT1159024B (it) 1983-06-02 1987-02-25 Ruggero Cadossi Metodo e dispositivo per il trattamento di tessuti e cellule viventi mediante campi elettromagnetici pulsanti
US4600010A (en) * 1984-10-04 1986-07-15 Biolectron, Inc. Electric stimulator and test instrument therefor
US5014699A (en) 1986-05-23 1991-05-14 Trustees Of The University Of Pennsylvania Electromagnetic method and apparatus for healing living tissue
US4998532A (en) 1986-05-23 1991-03-12 Lti Biomedical, Inc. Portable electro-therapy system
US6120502A (en) 1988-06-13 2000-09-19 Michelson; Gary Karlin Apparatus and method for the delivery of electrical current for interbody spinal arthrodesis
US5038797A (en) 1990-02-20 1991-08-13 Romaine, Incorporated Electrical stimulation treatment device and method of use
US5273033A (en) 1991-09-19 1993-12-28 Murray Electronics Associates Limited Partnership Electrical stimulation for treatment of osteoarthritis
US5338286A (en) 1992-12-08 1994-08-16 Electro-Biology, Inc. Electromagnetic bioresponse by selective spectral suppression in pulsed field stimulation
US5374283A (en) 1993-12-01 1994-12-20 Flick; A. Bart Electrical therapeutic apparatus
US6132362A (en) 1996-11-01 2000-10-17 Amei Technologies, Inc. Pulsed electromagnetic field (PEMF) stimulation therapy system with bi-phasic coil
US6261221B1 (en) 1996-11-01 2001-07-17 Amei Technologies Inc. Flexible coil pulsed electromagnetic field (PEMF) stimulation therapy system
US5743844A (en) 1996-11-01 1998-04-28 Amei Technologies, Inc. High efficiency pulsed electromagnetic field (PEMF) stimulation therapy method and system
US5968527A (en) 1997-02-27 1999-10-19 Catholic University Of America, The Protection of living systems from the adverse effects of stress
US6083149A (en) 1997-10-22 2000-07-04 Emf Therapeutics, Inc. Magnetic field device and method for inhibiting angiogenesis and retarding growth rates of tumors in mammals
US6186940B1 (en) 1998-05-18 2001-02-13 Robert N. Kirschbaum Energized trace elements
US6292699B1 (en) 1999-01-29 2001-09-18 Electro-Biology, Inc. Direct current stimulation of spinal interbody fixation device
JP2003525591A (ja) 1999-04-29 2003-09-02 ノース・ショア・ロング・アイランド・ジューイッシュ・リサーチ・コーポレイション 神経組織の成長の誘導および生存の増強方法
DE19933719A1 (de) 1999-07-19 2001-01-25 Medigene Ag Strukturprotein in Adeno-assoziiertem Virus mit veränderten chromatographischen Eigenschaften, seine Herstellung und Verwendung
US6919205B2 (en) 2000-02-23 2005-07-19 The Trustees Of The University Of Pennsylvania Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals
US7465566B2 (en) 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of genes via application of specific and selective electrical and electromagnetic signals
US7429471B2 (en) 2000-02-23 2008-09-30 The Trustees Of The University Of Pennsylvania Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
US7022506B2 (en) 2000-02-23 2006-04-04 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
US7130692B2 (en) 2000-02-23 2006-10-31 The Trustees Of The University Of Pennsylvania Portable electrotherapy device for treating osteoarthritis and other diseases, defects and injuries of the knee joint
US7465546B2 (en) 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of transforming growth factor-beta (TGF-β) gene expression in living cells via the application of specific and selective electric and electromagnetic fields
US6485963B1 (en) 2000-06-02 2002-11-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Growth stimulation of biological cells and tissue by electromagnetic fields and uses thereof
CA2427522A1 (en) 2000-11-02 2002-05-10 Keith L. March Method and system for modulation of oscillating signals to enhance biologic effects
US6485113B2 (en) 2001-03-08 2002-11-26 Delphi Technologies, Inc. Haptic braking method and system
AU2002318466A1 (en) 2001-07-03 2003-01-21 The Trustees Of The University Of Pennsylvania Device and method for electrically inducing osteogenesis in the spine
AU2002329223B2 (en) 2001-12-21 2007-11-22 The Trustees Of The University Of Pennsylvania Device for treating osteoporosis, hip and spine fractures and fusions with electric fields
US6955642B1 (en) 2002-11-26 2005-10-18 Ebi, Lp Pulsed electromagnetic field stimulation method and apparatus with improved dosing
MXPA06005358A (es) 2003-11-14 2006-07-10 Univ Pennsylvania Metodo y aparato para el tratamiento de la osteoartritis, enfermedades de los cartilagos, defectos y lesiones en la cadena humana.
AU2005206794B2 (en) 2004-01-12 2010-09-16 The Trustees Of The University Of Pennsylvania Up-regulation of bone morphogenetic protein (BMP) gene expression in bone cells by electromagnetic signals

Also Published As

Publication number Publication date
JP4344321B2 (ja) 2009-10-14
MXPA05003259A (es) 2005-09-12
WO2004029210A3 (en) 2005-02-10
US20030125769A1 (en) 2003-07-03
ES2622076T3 (es) 2017-07-05
JP2006500989A (ja) 2006-01-12
BR0314807A (pt) 2005-08-09
WO2004029210A2 (en) 2004-04-08
US7374916B2 (en) 2008-05-20
ZA200503041B (en) 2006-10-25
CN100446743C (zh) 2008-12-31
CN1694674A (zh) 2005-11-09
EP1560553A2 (en) 2005-08-10
CA2500212A1 (en) 2004-04-08
EP1560553A4 (en) 2007-09-12
NZ539310A (en) 2007-08-31
KR20050059198A (ko) 2005-06-17
EP1560553B1 (en) 2017-01-25
AU2003276961A1 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
NO20052254L (no) Regulering av type II collagen-genekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler
NO20060193L (no) Regulering av matriksmetallproteinasegenekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler
NO20063444L (no) System og metode for oppregulering av benmorfogenetisk proteingenekspresjon i benceller ved anvendelse av felt generert av spesifikke og selektive elektriske og elektromagnetiske signaler
WO2004029210A3 (en) Resolution of aggrecan gene expression using specific and selective electrical and electromagnetic signals
Orapiriyakul et al. Nanovibrational stimulation of mesenchymal stem cells induces therapeutic reactive oxygen species and inflammation for three-dimensional bone tissue engineering
Yajima et al. Non‐equilibrium atmospheric pressure plasmas modulate cell cycle‐related gene expressions in melanocytic tumors of ret‐transgenic mice
Schuettengruber et al. Genome regulation by polycomb and trithorax proteins
Besaratinia et al. Riboflavin activated by ultraviolet A1 irradiation induces oxidative DNA damage-mediated mutations inhibited by vitamin C
Furner et al. Methylation and demethylation of the Arabidopsis genome
DE50013093D1 (de) Sequenz-spezifische dna-rekombination in eukaryotischen zellen
Puce et al. Abscisic acid signaling through cyclic ADP-ribose in hydroid regeneration
Stimpfel et al. New challenge: mitochondrial epigenetics?
Sczepanski et al. Scope and mechanism of interstrand cross-link formation by the C4′-oxidized abasic site
KR101248668B1 (ko) 저온 상압 플라즈마 노출을 이용한 세포의 생장 조절 방법
Tuli et al. p38 MAP kinase regulation of AP‐2 binding in TGF‐β1‐stimulated chondrogenesis of human trabecular bone‐derived cells
Salem Biological networks: An introductory review
Bhullar et al. Tripeptide IRW upregulates NAMPT protein levels in cells and obese C57BL/6J mice
Le Vu et al. Effects of food-derived collagen peptides on the expression of keratin and keratin-associated protein genes in the Mouse Skin
Namula et al. Zona pellucida treatment before CRISPR/Cas9‐mediated genome editing of porcine zygotes
WO2004022782A3 (en) Compositions and methods for tissue specific or inducible inhibition of gene expression
Padalko et al. Peroxynitrite inhibition of Coxsackievirus infection by prevention of viral RNA entry
Chen et al. The role of epigenetic modifications in the osteogenic differentiation of adipose-derived stem cells
Pang et al. Effects of miR-143 and its target receptor 5-HT2B on agonistic behavior in the Chinese mitten crab (Eriocheir sinensis)
Nagai et al. Identification of a second messenger of crustacean hyperglycemic hormone signaling pathway in the kuruma prawn Marsupenaeus japonicus
Duggal et al. Promising Preliminary Activity of Optimized Affinity, CD38 CAR NK Cells Generated Using a Non-Viral Engineering Approach in Gene Edited Cord Blood Derived NK Cells for the Treatment of Multiple Myeloma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application